Financials
- Market Capitalization 3.87 B
- Employee 562
- Founded 2012
- CEO Carl Hansen
- Website www.abcellera.com
- Headquarter British Columbia, Canada
- FIGI BBG00LLW2MF2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.98
Relación precio/flujo de caja
13.6
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1455 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.28 USD | -1.13% | -4.06% | +1.94% | +46.47% | 4.03 B USD | ||
| 1473 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 36.28 USD | -5.64% | -8.52% | -18.82% | +138.21% | 3.94 B USD | ||
| 1500 | RLAY Relay Therapeutics, Inc. - Common Stock | 17.36 USD | -3.45% | -5.65% | -8.87% | +187.42% | 3.80 B USD | ||
| 1511 | TNGX Tango Therapeutics, Inc. - Common Stock | 22.22 USD | -8.07% | +2.68% | -9.49% | +154.23% | 3.75 B USD |